The healthcare sector will register the most rapid demand gains of any major single-use battery market, averaging 5.9 percent per year through 2020, much faster than the overall single-use battery market growth of just 1.5 percent annually. Growth will be bolstered by the rising numbers of elderly people, who are generally the most intensive users of battery-driven medical devices and instruments. Among the healthcare products employing single-use batteries are defibrillators, drug pumps, glucose monitors, heart monitors, neurostimulation and neuromodulation systems, and pacemakers. These and other trends are presented in Single-Use (Primary) Batteries in the US, a new study from The Freedonia Group, a Cleveland-based industry research firm.
Primary lithium batteries are especially prevalent in healthcare applications. Analyst E. Reta Sober states, “In fact, virtually all implantable cardioverter defibrillators and cardiac resynchronization therapy devices currently on the market utilize lithium-silver vanadium oxide batteries, while most cardiac pacemakers use lithium-iodine batteries.”
Similarly, the increasing incidence of diabetes, particularly type 2 (non-insulin-dependent diabetes mellitus), in the US will promote replacement sales of single-use batteries, such as CR2032 lithium types, that are used in glucometers. Faster advances will be restrained by a trend toward the use of rechargeable batteries in glucometers. EaglePicher Technologies, Integer, and Quallion (EnerSys) are leading suppliers of single-use batteries to the healthcare market.
Single-Use (Primary) Batteries in the US (published 11/2016, 114 pages) is available for $4900 from The Freedonia Group. For further details or to arrange an interview with the analyst, please contact Corinne Gangloff by phone 440.684.9600 or email [email protected].
Related studies include:
#3458 Rechargeable (Secondary) Batteries (September 2016)
#3309 World Batteries (July 2015)